BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6608813)

  • 1. Persistence and specificity of accessory cell impairment in M-MuLV neonatally injected mice.
    Biasi G; Saggin L; Dazzi F; Collavo D
    Transplant Proc; 1983 Dec; 15(4):2125-7. PubMed ID: 6608813
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice.
    Biasi G; Collavo D; Chieco-Bianchi L
    J Immunol; 1983 Jul; 131(1):16-8. PubMed ID: 6223070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 5. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G; Facchinetti A; Panozzo M; Zanovello P; Chieco-Bianchi L; Collavo D
    J Immunol; 1991 Oct; 147(7):2284-9. PubMed ID: 1833453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
    Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
    J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro suppression of cytotoxic T cell generation by lymphocytes from mice rendered neonatally tolerant of class II MHC alloantigens.
    Powell TJ; Streilein JW
    Transplantation; 1991 Aug; 52(2):383-6. PubMed ID: 1831305
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):538-44. PubMed ID: 6447123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VII. Kinetic studies on various parameters of effects induced with suppressor cells.
    Deutsch O; Devens B; Naor D
    Isr J Med Sci; 1980 Jul; 16(7):530-7. PubMed ID: 6447122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell interactions in leukemia-associated immunosuppression: suppression of thymus-independent antibody responses by leukemia spleen cells (Moloney) in vitro is mediated by normal T cells.
    Caulfield MJ; Cerny J
    J Immunol; 1980 Jan; 124(1):255-60. PubMed ID: 6965291
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that precursor cytotoxic T cells are present but silenced.
    Matriano JA; Socarras S; Streilein JW
    J Immunol; 1994 Aug; 153(4):1515-26. PubMed ID: 8046230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation.
    Enjuanes L; Lee JC; Ihle JN
    J Immunol; 1981 Apr; 126(4):1478-84. PubMed ID: 6970777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of Moloney virus induced antigen on antibody-producing cells.
    Celada F; Asjö B; Klein G
    Clin Exp Immunol; 1970 Mar; 6(3):317-23. PubMed ID: 4909958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
    Ihle JN; Lee JC; Rebar L
    J Immunol; 1981 Dec; 127(6):2565-70. PubMed ID: 6795277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance of AKR mice to the oncogenic action of Moloney murine sarcoma virus].
    Tsysina EN; Irlin IS
    Biull Eksp Biol Med; 1971 Oct; 72(10):85-8. PubMed ID: 5126159
    [No Abstract]   [Full Text] [Related]  

  • 20. Clonal analysis of the T lymphocyte response to murine sarcoma virus-induced tumors.
    Brunner KT; Weiss A; Cerottini JC; MacDonald HR
    Transplant Proc; 1982 Sep; 14(3):556-8. PubMed ID: 6217605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.